PMID-sentid	Pub_year	Sent_text		comp_official_name	comp_offsetprotein_name	organism	prot_offset
10658532-1	1999	Our early reports have indicated that vitamin K3 (VK3) exerts antitumour activity by inhibiting Cdk1 activity and overexpressing the c-myc gene to induce an apoptotic cell death.	Vitamin K 3	38-48	cyclin dependent kinase 1	Homo sapiens	96-100	
33982750-6	2021	Increased CDK1 expression was confirmed in HNSCC cells, and menadione, the top predicted potential drug, exerted significant inhibitory effects against HNSCC cell proliferation and markedly reversed CDK1 expression.	Vitamin K 3	60-69	cyclin dependent kinase 1	Homo sapiens	199-203	
8382492-0	1993	Vitamin K3 inhibits growth of human hepatoma HepG2 cells by decreasing activities of both p34cdc2 kinase and phosphatase.	Vitamin K 3	0-10	cyclin dependent kinase 1	Homo sapiens	90-97	
8382492-6	1993	Our results suggest that vitamin K3 inhibits the growth of HepG2 cells via a cell cycle progression delay and altered phosphorylation patterns and activities of both p34cdc2 kinase and protein-tyrosine phosphatase.	Vitamin K 3	25-35	cyclin dependent kinase 1	Homo sapiens	166-173